This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (17)  • Contact me when this article is cited  Related Content  • Related letter  • Similar articles in this journal  Topic Collections  • Review  • Randomized Controlled Trial  • Prognosis/ Outcomes  • Treatment Adherence  • Adherence  • Alert me on articles by topic

A Systematic Review

Sunil Kripalani, MD, MSc; Xiaomei Yao, MD; R. Brian Haynes, MD, PhD

Arch Intern Med. 2007;167(6):540-549.

Background  Approximately 20% to 50% of patients are not adherent to medical therapy. This review was performed to summarize, categorize, and estimate the effect size (ES) of interventions to improve medication adherence in chronic medical conditions.

Methods  Randomized controlled trials published from January 1967 to September 2004 were eligible if they described 1 or more unconfounded interventions intended to enhance adherence with self-administered medications in the treatment of chronic medical conditions. Trials that reported at least 1 measure of medication adherence and 1 clinical outcome, with at least 80% follow-up during 6 months, were included. Study characteristics and results for adherence and clinical outcomes were extracted. In addition, ES was calculated for each outcome.

Results  Among 37 eligible trials (including 12 informational, 10 behavioral, and 15 combined informational, behavioral, and/or social investigations), 20 studies reported a significant improvement in at least 1 adherence measure. Adherence increased most consistently with behavioral interventions that reduced dosing demands (3 of 3 studies, large ES [0.89-1.20]) and those involving monitoring and feedback (3 of 4 studies, small to large ES [0.27-0.81]). Adherence also improved in 6 multisession informational trials (small to large ES [0.35-1.13]) and 8 combined interventions (small to large ES [absolute value, 0.43-1.20]). Eleven studies (4 informational, 3 behavioral, and 4 combined) demonstrated improvement in at least 1 clinical outcome, but effects were variable (very small to large ES [0.17-3.41]) and not consistently related to changes in adherence.

Conclusion  Several types of interventions are effective in improving medication adherence in chronic medical conditions, but few significantly affected clinical outcomes.

Author Affiliations: Division of General Medicine, Department of Internal Medicine, Emory University School of Medicine, Atlanta, Ga (Dr Kripalani); and Department of Clinical Epidemiology and Biostatistics (Drs Yao and Haynes) and Department of Medicine (Dr Haynes), McMaster University, Hamilton, Ontario.

RELATED LETTER

Evidence Needed for Policy Decisions: Adherence Interventions and Medicare Part D
Daniel R. Touchette and Andrew L. Masica
Arch Intern Med. 2007;167(17):1905.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pharmacoadherence: A new term for a significant problem
Chisholm-Burns and Spivey
Am J Health Syst Pharm 2008;65:661-667.
FULL TEXT  

Cost-Effectiveness of Providing Full Drug Coverage to Increase Medication Adherence in Post-Myocardial Infarction Medicare Beneficiaries
Choudhry et al.
Circulation 2008;117:1261-1268.
ABSTRACT | FULL TEXT  

Working With Patients to Enhance Medication Adherence
Lin and Ciechanowski
Clin. Diabetes 2008;26:17-19.
FULL TEXT  

Asymmetric Paternalism to Improve Health Behaviors
Loewenstein et al.
JAMA 2007;298:2415-2417.
FULL TEXT  

Evidence Needed for Policy Decisions: Adherence Interventions and Medicare Part D
Touchette and Masica
Arch Intern Med 2007;167:1905-1905.
FULL TEXT